Rakicidin A effectively induces apoptosis in hypoxia adapted Bcr-Abl positive leukemic cells. (Q54626064)

1 June 2018

title

Rakicidin A effectively induces apoptosis in hypoxia adapted Bcr-Abl positive leukemic cells. (English)

1 reference

1 June 2018

0 references

1 reference

Miki Takeuchi

1

1 reference

1 June 2018

Eishi Ashihara

2

1 reference

1 June 2018

Yohko Yamazaki

3

1 reference

1 June 2018

Shinya Kimura

4

1 reference

1 June 2018

Yoko Nakagawa

5

1 reference

1 June 2018

Ruriko Tanaka

6

1 reference

1 June 2018

Hisayuki Yao

7

1 reference

1 June 2018

Rina Nagao

8

1 reference

1 June 2018

Yoshihiro Hayashi

9

1 reference

1 June 2018

Hideyo Hirai

10

1 reference

1 June 2018

Taira Maekawa

11

1 reference

1 June 2018

publication date

19 December 2010

1 reference

1 June 2018

published in

Cancer Science

1 reference

1 June 2018

volume

102

1 reference

1 June 2018

issue

3

1 reference

1 June 2018

page(s)

591-596

1 reference

1 June 2018

Oxygen status of malignant tumors: pathogenesis of hypoxia and significance for tumor therapy

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01813.X

Tumor hypoxia: a target for selective cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01813.X

Why do cancers have high aerobic glycolysis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01813.X

Exploiting tumour hypoxia in cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01813.X

Distribution of hematopoietic stem cells in the bone marrow according to regional hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01813.X

21 January 2018

Chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01813.X

Chronic Myeloid Leukemia — Advances in Biology and New Approaches to Treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01813.X

Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01813.X

Dynamics of chronic myeloid leukaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01813.X

Dasatinib (BMS-354825) targets an earlier progenitor population than imatinib in primary CML but does not eliminate the quiescent fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01813.X

Glyoxalase-I is a novel target against Bcr-Abl+ leukemic cells acquiring stem-like characteristics in a hypoxic environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01813.X

Rakicidin A: a hypoxia-selective cytotoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01813.X

Drug combination studies and their synergy quantification using the Chou-Talalay method

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01813.X

Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01813.X

Antiproliferative efficacy of the third-generation bisphosphonate, zoledronic acid, combined with other anticancer drugs in leukemic cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01813.X

The Bcr-Abl kinase inhibitor INNO-406 induces autophagy and different modes of cell death execution in Bcr-Abl-positive leukemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01813.X

A novel mechanism for imatinib mesylate-induced cell death of BCR-ABL-positive human leukemic cells: caspase-independent, necrosis-like programmed cell death mediated by serine protease activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01813.X

A combination of a DNA-chimera siRNA against PLK-1 and zoledronic acid suppresses the growth of malignant mesothelioma cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01813.X

Abl tyrosine kinase inhibitors for overriding Bcr-Abl/T315I: from the second to third generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01813.X

Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01813.X

Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01813.X

Increased cellular hypoxia and reduced proliferation of both normal and leukaemic cells during progression of acute myeloid leukaemia in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01813.X

Severe hypoxia defines heterogeneity and selects highly immature progenitors within clonal erythroleukemia cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01813.X

Imatinib therapy in chronic myelogenous leukemia: strategies to avoid and overcome resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01813.X

Hypoxia modifies proliferation and differentiation of CD34(+) CML cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01813.X

Suppression of postmitochondrial signaling and delayed response to UV-induced nuclear apoptosis in HeLa cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01813.X

Apoptosis-inducing factor (AIF): a novel caspase-independent death effector released from mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01813.X

Micro-calpain regulates caspase-dependent and apoptosis inducing factor-mediated caspase-independent apoptotic pathways in cisplatin-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01813.X

SR-4233: a new bioreductive agent with high selective toxicity for hypoxic mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01813.X

Comparison of in vivo efficacy of hypoxic cytotoxin tirapazamine and hypoxic cell radiosensitizer KU-2285 in combination with single and fractionated irradiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01813.X

Usefulness of tirapazamine as a combined agent in chemoradiation and thermo-chemoradiation therapy at mild temperatures: reference to the effect on intratumor quiescent cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01813.X

Role of hydrogen peroxide and hydroxyl radical formation in the killing of Ehrlich tumor cells by anticancer quinones

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01813.X

Free radicals and anticancer drug resistance: oxygen free radicals in the mechanisms of drug cytotoxicity and resistance by certain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2010.01813.X

10.1111/J.1349-7006.2010.01813.X

21 January 2018

Identifiers

DOI

1 reference

1 June 2018

PubMed ID

21166958

1 reference

1 June 2018